Rapid confirmation of HIV infection

International Journal of Infectious Diseases

Volumn 6, Issue 3, 2002, Pages 170-177

  Constantine, Niel T ^a   Ketema, Fassil ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; REPRODUCIBILITY; ANALYTICAL EQUIPMENT; BLOOD; COMPARATIVE STUDY; EVALUATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; STANDARD; TIME; VIROLOGY; WESTERN BLOTTING;

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

AIDS SERODIAGNOSIS; BLOTTING, WESTERN; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0036738893     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(02)90106-2     Document Type: Article

References (34)

1. Auxter S. Bringing rapid HIV tests to market more quickly. Clin Lab News 2000; 26(1):10.
2. Simon F, Ly TD, Baillou-Beaufils A, et al. Sensitivity of screening kits for anti-HIV-1 subtype-O antibodies. AIDS 1994; 8:1628-1629.
3. Stetler HC, Granade TC, Nunez CA, et al. Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. AIDS 1997; 11:369-375.
4. Centers for Disease Control and Prevention. Guidelines for the management of health care worker exposures to HIV and recommendations for postexposure prophylaxis. MMWR 1998; 47:3.
5. Wade NA, Birkhead GS, Warren BL. Abbreviated regimens of zidovudine prophylaxis and prenatal transmission of the human immunodeficiency virus. N Engl J Med 1998; 339:1409-1414.
6. Centers for Disease Control and Prevention. Update: HIV counseling and testing using rapid tests United States 1995. MMWR 1998; 47:211-215.
7. Kane B. Rapid testing for HIV: why so fast? Ann Intern Med 1999; 131:481-483.
8. Auxter S. The movement toward expedited maternal and newborn HIV testing. Clin Lab News 1999; 25(1):8-9.
9. Fransen K, Pollet DE, Peeters M, et al. Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2. Eur J Clin Microbiol Infect Dis 1991; 10:939-946.
10. Constantine NT. Serologic tests for the retroviruses: approaching a decade of evolution. AIDS 1993; 7:1-13.
11. Centers for Disease Control and Prevention. Interpretations and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR 1989; 38:1-7.
12. Food and Drug Administration. Licensed/approved HIV, HTLV and hepatitis tests. Updated August 29, 2000. Available from:www.fda.gov/cber/products/testkits.htm.
13. Desai S, Bates H, Michalski FJ. Detection of antibody to HIV-1 in urine. Lancet 1991; 337:183-184.
14. Farzadegan H, Quinn T, Frank B. Detecting antibodies to human immunodeficiency virus in dried blood on filter papers. J Infect Dis 1987; 55:1073-1074.
15. Constantine NT, Callahan JD, Watts DM. Retroviral testing: essentials for quality control and laboratory diagnosis. Boca Raton, FL: CRC Press, 1992.
16. Saville R, Constantine NT, Depaola L, Wisnour C, Falker W. Evaluation of HIV-1/2 rapid/simple assays to detect HIV antibodies in oral fluids. J Clin Lab Anal 1997; 11: 63-68.
17. Arai H, Petchclai B, Khupulsup K, Kurimura T, Takeda K. Evaluation of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus. J Clin Microbiol 1999; 37(2):367-370.
18. Weber B, Fall EH, Berger A, Doerr HW. Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol 1998; 36(8):2235-2239.
19. Gurtler L, Muglbacher A, Michl U, et al. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J Virol Methods 1998; 75:27-38.
20. Saville RD, Constantine NT, Cleghorn FR, et al. Fourth generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency antigen and antibody. J Clin Microbiol 2001; 39:2518-2524.
21. American Association of Blood Banks. HIV-1 antigen test implementation guidance. AABB Assoc Bull 1996; No. 92-2.
22. Food and Drug Administration. Guidance for industry application of current statutory authority to nucleic acid testing of pooled plasma. Draft guidance. Updated March 17, 2001. Available from: www.fda.gov/cber/gdlns/ppnat.txt.
23. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280:42-48.
24. Constantine NT, Cafarella T, Cleghorn F. Simplified detuning strategies. Abstract PS18. In: Abstracts of the 15th Annual Meeting of the Association of Public Health Laboratories, 2000.
25. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-1170.
26. Myers RA, Szuch WF, Patel JD, Joseph JM. Detection of higher HIV-1 viral load levels (>1.1 log) using a ultra sensitive branched D Chain (bDNA) Assay in five nonclade B HIV-1 infected patients with low HIV-1 viral loads (<500 copies/ml) in the standard RT/PCR based assay. Abstract P18. In: Abstracts of the Conference on the Laboratory Science of HIV, 1998.
27. Hirsch MS, Conway B, Daquila RT, et al. Antiretroviral drug resistance testing in adults with HIV infection. JAMA 1998; 279:1984-1991.
28. Gurtler L, Zekeng L, Simon F, et al. Reactivity of five antiHIV-1 subtype O specimens in six different anti-HIV screening ELISAs and three immunoblots. J Virol Methods 1995; 51:177-184.
29. Constantine NT, Zekeng L, Sangare A, et al. Diagnostic challenges for rapid HIV assays: performance using HIV-1 group O, group M, and HIV-2 samples. J Human Virol 1997; 1:46-52.
30. Cheingsong-Popov R, Callow D, Beddows S, et al. Geographical diversity of HIV-1: serologic reactivity to env epitopes and relationship to neutralization. J Infect Dis 1992; 165:256-261.
31. Tamashiro H, Maskill W, Emmanuel J, et al. Reducing the cost of HIV antibody testing. Lancet 1993; 342:87-90.
32. Chan EL, Sidaway F, Horsman GB. A comparison of the Genie and Western blot assays in confirmatory testing for HIV-1 antibody. J Med Microbiol 1996; 44:223-225.
33. Boston Biomedica, Inc. Seroconversion panels data sheets. Boston Biomedica, Inc.: West Bridgewater, Massachusetts, 1997.
34. Constantine NT. Intervening in blood supply and use systems. In: Gibney L, DiClemente J, Vermund S, eds. Preventing HIV in developing countries: biomedical and behavioral approaches. New York: Plenum, 1999:71-85.